Transplantation Immunology (Hillebrands, Sanders, Kroesen)

27 important questions on Transplantation Immunology (Hillebrands, Sanders, Kroesen)

The location of a graft can be orthotopic or heterotopic. What is the difference?

Orthotopic means that the graft is placed in its "original" place, the graft is replacing the organ of the recipient.

Heterotopic means that graft is not placed in its "original" place. For example a kidney transplantation where the dysfunctional kidney is left in the recipient.

What is the difference between a autograft, isograft/syngeneic graft, allograft, and xenograft?

Autograft -> from one part of the body to another in the same body.

Isograft -> between genetically identical individuals, for example monozygotic twins

allograft -> between different member of the same species   

xenograft -> between two different species, for examples human and pig

Why was the first kidney transplantation in 1954 a succes?

The kidney transplantation took place between identical twins.
  • Higher grades + faster learning
  • Never study anything twice
  • 100% sure, 100% understanding
Discover Study Smart

Name four challenges of solid organ transplantation

- Surgical techniques
- Donor shortage
- Donor organ preservation
- Graft rejection

Is graft rejection mediated by the adaptive or innate immune system? And by which cell is this primarily mediated?

It is an adaptive immune response.
Primarily T cell-mediated.

Based on MHC polymorphic genes, which grafts are rejected?

Fully allogeneic graft is rejected.
Graft from F1 hybrid is rejected by parental strain. (So MHCaxb rejects the graft from MHCa and MHCb)

An allo-response is an extremely strong response (responding T-cell: 1-10% vs 0.001-0.0001%) Why do so many T cells respond to allo-MHC?

Cross-reactivity of T cells with allo-MHC.

- no negative selection of T cells with affinity for allo-MHC (in contrast with self-MHC)
- higher density of alloantigens of allogeneic APC
- self peptides presented in allo MHC will also be recognized
- alloresponse is mediated (in part) by expanded clones of (memory) T cells

What happens during direct recognition of allo-MHC by T cells?

Allogeneic APC in graft carries allogeneic MHC.
T cell (both CD4+ (classII) and CD8+ (classI) recognized unprocessed allogeneic MHC molecule on graft APC.  
NO NEED HOST APCs!!

What are the different outcomes of direct and indirect recognition of alloMHC?

Direct alloantigen recognition leads to direct CTL killing of the graft cells.

Indirect alloantigen recognition leads to:
- antibody-mediated injury to graft cells
- inflammation-mediated injury to graft

What happens during indirect recognition of alloMHC by T cells?

1) The recipients APC uptake and proces allogeneic MHC.

2) Self APC present the allo-MHC bound to self MHC molecule.

3) Alloreactive T cell reacts (CD8+)

What are the basic steps from sensitation to graft rejection?

1) Transport of alloantigens to lymph node (self and nonself APCs)

2) Activation of T cells, generation of effector T cells by direct and indirect presentation

3) Migration of effector T cells to allograft

4) Killing of graft tissue cells and cytokine secretion lead to graft rejection.

What are the characteristic of hyperacute rejection?

- Takes place minutes/hours after transplantation
- Pre-existing antibodies against endothelial antigens  (for example bloodgroup antigens(carbohydrates), MHC and mHC antigens (proteins) and xeno-antigens.

leads to complement activation -> thrombosis, endothelial damage, inflammation -> occlusion

Acute rejection is a cell- and/or antibody-mediated response that occurs days/weeks after transplantation.

Describe the characteristics of acute cellular rejection.

The target are the parenchymal cells.

A parenchymal infiltrate of CD4+ T cells (Th1, Th17) and CD8+ CTL causes recruitment of inflammatory cells (macrophages and neutrophils) and lysis.

-Parenchymal cell damage, interstitial inflammation.

Acute rejection is a cell- and/or antibody-mediated response that occurs days/weeks after transplantation.

Describe the characteristics of acute antibody-mediated rejection.

The target are the endothelial cells.

Antibody binding to endothelium --> complement activation --> lysis and thrombus formation
Antibody binding to Fc-R on neutrophils and NK cells --> lysis endothelial cells.

- Endotheliitis

What are the characteristics of chronic graft rejection?

- Months/years after transplantation

- Multi factorial process  (CD4+ T cells, cytokines, macrophages)

- Chronic inflammatory reaction in vessel wall --> fibrosis and transplant vasculopathy (graft arteriosclerosis) caused by the proliferation of  vascular smooth muscle cells (VSMC)

How can graft rejection be prevented and treated?

- Reducing immunogenicity through ABO and HLA matching between donor and recipient.

- Preserving donor organ quality

- Suppression of the immune system (immunosuppressive drugs)

The graft survival rates after use of Cyclosporine showed a positive effect. What is the immunosuppressive mechanism behind this?

Inhibition of T cell signalling by inhibiting calcineurin

What are other mechanisms of immunosuppressive medicine on T cells besides cyclosporine?

-inhibition of T cell proliferation
- killing of proliferating cells (antimetabolites)
- depletion of T cells
- costimulatory blockade (B7)

How can B cell activity be suppressed?

- suppression of antibody production (rapamycin, rituximab)
- plasmapheresis

What is the "dark side" of immunosuppression?

- increased susceptibility to viral infections and virus-associated malignancies (herpesviruses, opportunistic infections)

- B cell-derived lymphomas

- diabetes, hypertension

- cardiovascular disease

- nephrotoxicity

Who can donate organs?

- heart beating donors/heart beating brain-dead donors
- non heart beating donors
- living donors

Organ survival is determined by:

- HLA-matching between donor and recipient
- presence of HLA-antibodies in the recipient
- immunosuppressive medication

From what events are HLA-antibodies formed?

Immunogenic/sensitizing events:

- bloodtransfusion
- pregnancy
- previous transplantations

HLA-typing is the combination of all HLA-molecules expressed by an individual. There are alleles in HLA-class I and HLA-class II,
which are they? And what is the maximal possibility of different HLA-molecules?

HLA-class I: A, B, Cw: maximal 6 HLA alleles
HLA-class II: DR, DP, DQ: maximal 6 HLA alleles

total: maximal possibilities: 12 different HLA-molecules

What HLA linkage disequilibrium is the strongest between which alleles?

B- and C- locus
DR- and DQ-locus

What are two forms of analysis of HLA-antibodies?

- complement dependent cytotoxicity (CD)
  = incubation of patient-serum with lymphocytes of a selected panel of individuals.   least sensitive but clinically most relevant.

- luminex single antigen assay (LSA)
  = incubation of patient serum with beads, coated with specific HLA-molecules. highly sensitive and discriminative between specific HLA-molecules.

Which HLA polymorphism is on a higher level, genetic or protein?

HLA-polymorphism at the genetic level extends HLA-polymorphims at the protein level.

The question on the page originate from the summary of the following study material:

  • A unique study and practice tool
  • Never study anything twice again
  • Get the grades you hope for
  • 100% sure, 100% understanding
Remember faster, study better. Scientifically proven.
Trustpilot Logo